<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.globalizationandhealth.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Globalization and Health - Most accessed articles</title>
        <link>http://www.globalizationandhealth.com</link>
        <description>The most accessed research articles published by Globalization and Health</description>
        <dc:date>2011-05-04T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/1/1/14" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/3/1/5" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/1/1/13" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/2/1/4" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/3/1/6" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/3/1/2" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/2/1/9" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/6/1/6" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/7/1/12" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/5/1/7" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.globalizationandhealth.com/content/1/1/14">
        <title>The health impacts of globalisation: a conceptual framework</title>
        <description>This paper describes a conceptual framework for the health implications of globalisation. The framework is developed by first identifying the main determinants of population health and the main features of the globalisation process. The resulting conceptual model explicitly visualises that globalisation affects the institutional, economic, social-cultural and ecological determinants of population health, and that the globalisation process mainly operates at the contextual level, while influencing health through its more distal and proximal determinants. The developed framework provides valuable insights in how to organise the complexity involved in studying the health effects resulting from globalisation. It could, therefore, give a meaningful contribution to further empirical research by serving as a &apos;think-model&apos; and provides a basis for the development of future scenarios on health.</description>
        <link>http://www.globalizationandhealth.com/content/1/1/14</link>
                <dc:creator>Maud Huynen</dc:creator>
                <dc:creator>Pim Martens</dc:creator>
                <dc:creator>Henk Hilderink</dc:creator>
                <dc:source>Globalization and Health 2005, null:14</dc:source>
        <dc:date>2005-08-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-1-14</dc:identifier>
                                <prism:require>/content/figures/1744-8603-1-14-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2005-08-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/3/1/5">
        <title>Globalization and social determinants of health: Introduction and methodological background (part 1 of 3)

</title>
        <description>Globalization is a key context for the study of social determinants of health (SDH). Broadly stated, SDH are the conditions in which people live and work, and that affect their opportunities to lead healthy lives.In this first article of a three-part series, we describe the origins of the series in work conducted for the Globalization Knowledge Network of the World Health Organization&apos;s Commission on Social Determinants of Health and in the Commission&apos;s specific concern with health equity. We explain our rationale for defining globalization with reference to the emergence of a global marketplace, and the economic and political choices that have facilitated that emergence. We identify a number of conceptual milestones in studying the relation between globalization and SDH over the period 1987&#8211;2005, and then show that because globalization comprises multiple, interacting policy dynamics, reliance on evidence from multiple disciplines (transdisciplinarity) and research methodologies is required. So, too, is explicit recognition of the uncertainties associated with linking globalization &#8211; the quintessential &quot;upstream&quot; variable &#8211; with changes in SDH and in health outcomes.</description>
        <link>http://www.globalizationandhealth.com/content/3/1/5</link>
                <dc:creator>Ronald Labonte</dc:creator>
                <dc:creator>Ted Schrecker</dc:creator>
                <dc:source>Globalization and Health 2007, null:5</dc:source>
        <dc:date>2007-06-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-3-5</dc:identifier>
                                <prism:require>/content/figures/1744-8603-3-5-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2007-06-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/1/1/13">
        <title>HIV/AIDS: global trends, global funds and delivery bottlenecks</title>
        <description>Globalisation affects all facets of human life, including health and well being. The HIV/AIDS epidemic has highlighted the global nature of human health and welfare and globalisation has given rise to a trend toward finding common solutions to global health challenges. Numerous international funds have been set up in recent times to address global health challenges such as HIV.However, despite increasingly large amounts of funding for health initiatives being made available to poorer regions of the world, HIV infection rates and prevalence continue to increase world wide. As a result, the AIDS epidemic is expanding and intensifying globally. Worst affected are undoubtedly the poorer regions of the world as combinations of poverty, disease, famine, political and economic instability and weak health infrastructure exacerbate the severe and far-reaching impacts of the epidemic.One of the major reasons for the apparent ineffectiveness of global interventions is historical weaknesses in the health systems of underdeveloped countries, which contribute to bottlenecks in the distribution and utilisation of funds. Strengthening these health systems, although a vital component in addressing the global epidemic, must however be accompanied by mitigation of other determinants as well. These are intrinsically complex and include social and environmental factors, sexual behaviour, issues of human rights and biological factors, all of which contribute to HIV transmission, progression and mortality. An equally important factor is ensuring an equitable balance between prevention and treatment programmes in order to holistically address the challenges presented by the epidemic.</description>
        <link>http://www.globalizationandhealth.com/content/1/1/13</link>
                <dc:creator>Hoosen Coovadia</dc:creator>
                <dc:creator>Jacqui Hadingham</dc:creator>
                <dc:source>Globalization and Health 2005, null:13</dc:source>
        <dc:date>2005-08-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-1-13</dc:identifier>
                                <prism:require>/content/figures/1744-8603-1-13-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2005-08-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/2/1/4">
        <title>Uneven dietary development: linking the policies and processes of globalization with the nutrition transition, obesity and diet-related chronic diseases</title>
        <description>In a &quot;nutrition transition&quot;, the consumption of foods high in fats and sweeteners is increasing throughout the developing world. The transition, implicated in the rapid rise of obesity and diet-related chronic diseases worldwide, is rooted in the processes of globalization. Globalization affects the nature of agri-food systems, thereby altering the quantity, type, cost and desirability of foods available for consumption. Understanding the links between globalization and the nutrition transition is therefore necessary to help policy makers develop policies, including food policies, for addressing the global burden of chronic disease. While the subject has been much discussed, tracing the specific pathways between globalization and dietary change remains a challenge.To help address this challenge, this paper explores how one of the central mechanisms of globalization, the integration of the global marketplace, is affecting the specific diet patterns. Focusing on middle-income countries, it highlights the importance of three major processes of market integration: (I) production and trade of agricultural goods; (II) foreign direct investment in food processing and retailing; and (III) global food advertising and promotion.The paper reveals how specific policies implemented to advance the globalization agenda account in part for some recent trends in the global diet. Agricultural production and trade policies have enabled more vegetable oil consumption; policies on foreign direct investment have facilitated higher consumption of highly-processed foods, as has global food marketing. These dietary outcomes also reflect the socioeconomic and cultural context in which these policies are operating.An important finding is that the dynamic, competitive forces unleashed as a result of global market integration facilitates not only convergence in consumption habits (as is commonly assumed in the &quot;Coca-Colonization&quot; hypothesis), but adaptation to products targeted at different niche markets. This convergence-divergence duality raises the policy concern that globalization will exacerbate uneven dietary development between rich and poor. As high-income groups in developing countries accrue the benefits of a more dynamic marketplace, lower-income groups may well experience convergence towards poor quality obseogenic diets, as observed in western countries.Global economic polices concerning agriculture, trade, investment and marketing affect what the world eats. They are therefore also global food and health policies. Health policy makers should pay greater attention to these policies in order to address some of the structural causes of obesity and diet-related chronic diseases worldwide, especially among the groups of low socioeconomic status.</description>
        <link>http://www.globalizationandhealth.com/content/2/1/4</link>
                <dc:creator>Corinna Hawkes</dc:creator>
                <dc:source>Globalization and Health 2006, null:4</dc:source>
        <dc:date>2006-03-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-2-4</dc:identifier>
                                <prism:require>/content/figures/1744-8603-2-4-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2006-03-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/3/1/6">
        <title>Globalization and social determinants of health:
The role of the global marketplace (part 2 of 3)
</title>
        <description>Globalization is a key context for the study of social determinants of health (SDH): broadly stated, SDH are the conditions in which people live and work, and that affect their opportunities to lead healthy lives.In the first article in this three part series, we described the origins of the series in work conducted for the Globalization Knowledge Network of the World Health Organization&apos;s Commission on Social Determinants of Health and in the Commission&apos;s specific concern with health equity. We identified and defended a definition of globalization that gives primacy to the drivers and effects of transnational economic integration, and addressed a number of important conceptual and methodological issues in studying globalization&apos;s effects on SDH and their distribution, emphasizing the need for transdisciplinary approaches that reflect the complexity of the topic.In this second article, we identify and describe several, often interacting clusters of pathways leading from globalization to changes in SDH that are relevant to health equity. These involve: trade liberalization; the global reorganization of production and labour markets; debt crises and economic restructuring; financial liberalization; urban settings; influences that operate by way of the physical environment; and health systems changed by the global marketplace.</description>
        <link>http://www.globalizationandhealth.com/content/3/1/6</link>
                <dc:creator>Ronald Labonte</dc:creator>
                <dc:creator>Ted Schrecker</dc:creator>
                <dc:source>Globalization and Health 2007, null:6</dc:source>
        <dc:date>2007-06-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-3-6</dc:identifier>
                                    <dc:description></dc:description>
                <prism:require>/content/figures/1744-8603-3-6-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2007-06-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/3/1/2">
        <title>Non-communicable diseases and global health governance: enhancing global processes to improve health development</title>
        <description>This paper assesses progress in the development of a global framework for responding to non-communicable diseases, as reflected in the policies and initiatives of the World Health Organization (WHO), World Bank and the UN: the institutions most capable of shaping a coherent global policy. Responding to the global burden of chronic disease requires a strategic assessment of the global processes that are likely to be most effective in generating commitment to policy change at country level, and in influencing industry behaviour. WHO has adopted a legal process with tobacco (the WHO Framework Convention on Tobacco Control), but a non-legal, advocacy-based approach with diet and physical activity (the Global Strategy on Diet, Physical Activity and Health).The paper assesses the merits of the Millennium Development Goals (MDGs) and the FCTC as distinct global processes for advancing health development, before considering what lessons might be learned for enhancing the implementation of the Global Strategy on Diet. While global partnerships, economic incentives, and international legal instruments could each contribute to a more effective global response to chronic diseases, the paper makes a special case for the development of international legal standards in select areas of diet and nutrition, as a strategy for ensuring that the health of future generations does not become dependent on corporate charity and voluntary commitments. A broader frame of reference for lifestyle-related chronic diseases is needed: one that draws together WHO&apos;s work in tobacco, nutrition and physical activity, and that envisages selective use of international legal obligations, non-binding recommendations, advocacy and policy advice as tools of choice for promoting different elements of the strategy.</description>
        <link>http://www.globalizationandhealth.com/content/3/1/2</link>
                <dc:creator>Roger Magnusson</dc:creator>
                <dc:source>Globalization and Health 2007, null:2</dc:source>
        <dc:date>2007-05-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-3-2</dc:identifier>
                                <prism:require>/content/figures/1744-8603-3-2-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2007-05-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/2/1/9">
        <title>Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries?</title>
        <description>Background:
The ongoing policy debate about the value of communications technology in promoting development objectives is diverse. Some view computer/web/phone communications technology as insufficient to solve development problems while others view communications technology as assisting all sections of the population. This paper looks at evidence to support or refute the idea that fixed and mobile telephones is, or could be, an effective healthcare intervention in developing countries.
Methods:
A Web-based and library database search was undertaken including the following databases: MEDLINE, CINAHL, (nursing &amp; allied health), Evidence Based Medicine (EBM), POPLINE, BIOSIS, and Web of Science, AIDSearch (MEDLINE AIDS/HIV Subset, AIDSTRIALS &amp; AIDSDRUGS) databases.
Results:
Evidence can be found to both support and refute the proposition that fixed and mobile telephones is, or could be, an effective healthcare intervention in developing countries. It is difficult to generalize because of the different outcome measurements and the small number of controlled studies. There is almost no literature on using mobile telephones as a healthcare intervention for HIV, TB, malaria, and chronic conditions in developing countries. Clinical outcomes are rarely measured. Convincing evidence regarding the overall cost-effectiveness of mobile phone &quot; telemedicine&quot; is still limited and good-quality studies are rare. Evidence of the cost effectiveness of such interventions to improve adherence to medicines is also quite weak.
Conclusion:
The developed world model of personal ownership of a phone may not be appropriate to the developing world in which shared mobile telephone use is important. Sharing may be a serious drawback to use of mobile telephones as a healthcare intervention in terms of stigma and privacy, but its magnitude is unknown. One advantage, however, of telephones with respect to adherence to medicine in chronic care models is its ability to create a multi-way interaction between patient and provider(s) and thus facilitate the dynamic nature of this relationship. Regulatory reforms required for proper operation of basic and value-added telecommunications services are a priority if mobile telecommunications are to be used for healthcare initiatives.</description>
        <link>http://www.globalizationandhealth.com/content/2/1/9</link>
                <dc:creator>Warren Kaplan</dc:creator>
                <dc:source>Globalization and Health 2006, null:9</dc:source>
        <dc:date>2006-05-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-2-9</dc:identifier>
                                <prism:require>/content/figures/1744-8603-2-9-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2006-05-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/6/1/6">
        <title>Developing effective chronic disease interventions in Africa: insights from Ghana and Cameroon</title>
        <description>Background:
Africa faces an urgent but &apos;neglected epidemic&apos; of chronic disease. In some countries stroke, hypertension, diabetes and cancers cause a greater number of adult medical admissions and deaths compared to communicable diseases such as HIV/AIDS or tuberculosis. Experts propose a three-pronged solution consisting of epidemiological surveillance, primary prevention and secondary prevention. In addition, interventions must be implemented through &apos;multifaceted multi-institutional&apos; strategies that make efficient use of limited economic and human resources. Epidemiological surveillance has been prioritised over primary and secondary prevention. We discuss the challenge of developing effective primary and secondary prevention to tackle Africa&apos;s chronic disease epidemic through in-depth case studies of Ghanaian and Cameroonian responses.
Methods:
A review of chronic disease research, interventions and policy in Ghana and Cameroon instructed by an applied psychology conceptual framework. Data included published research and grey literature, health policy initiatives and reports, and available information on lay community responses to chronic diseases.
Results:
There are fundamental differences between Ghana and Cameroon in terms of &apos;multi-institutional and multi-faceted responses&apos; to chronic diseases. Ghana does not have a chronic disease policy but has a national health insurance policy that covers drug treatment of some chronic diseases, a culture of patient advocacy for a broad range of chronic conditions and mass media involvement in chronic disease education. Cameroon has a policy on diabetes and hypertension, has established diabetes clinics across the country and provided training to health workers to improve treatment and education, but lacks community and media engagement. In both countries churches provide public education on major chronic diseases. Neither country has conducted systematic evaluation of the impact of interventions on health outcomes and cost-effectiveness.
Conclusions:
Both Ghana and Cameroon require a comprehensive and integrative approach to chronic disease intervention that combines structural, community and individual strategies. We outline research and practice gaps and best practice models within and outside Africa that can instruct the development of future interventions.</description>
        <link>http://www.globalizationandhealth.com/content/6/1/6</link>
                <dc:creator>Ama de-Graft Aikins</dc:creator>
                <dc:creator>Petra Boynton</dc:creator>
                <dc:creator>Lem Atanga</dc:creator>
                <dc:source>Globalization and Health 2010, null:6</dc:source>
        <dc:date>2010-04-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-6-6</dc:identifier>
                                <prism:require>/content/figures/1744-8603-6-6-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2010-04-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/7/1/12">
        <title>Medical tourism and policy implications for health systems: a conceptual framework from a comparative study of Thailand, Singapore and Malaysia
</title>
        <description>Medical tourism is a growing phenomenon with policy implications for health systems, particularly of destination countries. Private actors and governments in Southeast Asia are promoting the medical tourist industry, but the potential impact on health systems, particularly in terms of equity in access and availability for local consumers, is unclear. This article presents a conceptual framework that outlines the policy implications of medical tourism&apos;s growth for health systems, drawing on the cases of Thailand, Singapore and Malaysia, three regional hubs for medical tourism, via an extensive review of academic and grey literature. Variables for further analysis of the potential impact of medical tourism on health systems are also identified. The framework can provide a basis for empirical, in country studies weighing the benefits and disadvantages of medical tourism for health systems. The policy implications described are of particular relevance for policymakers and industry practitioners in other Southeast Asian countries with similar health systems where governments have expressed interest in facilitating the growth of the medical tourist industry. This article calls for a universal definition of medical tourism and medical tourists to be enunciated, as well as concerted data collection efforts, to be undertaken prior to any meaningful empirical analysis of medical tourism&apos;s impact on health systems.</description>
        <link>http://www.globalizationandhealth.com/content/7/1/12</link>
                <dc:creator>Nicola Pocock</dc:creator>
                <dc:creator>Kai Hong Phua</dc:creator>
                <dc:source>Globalization and Health 2011, null:12</dc:source>
        <dc:date>2011-05-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-7-12</dc:identifier>
                                <prism:require>/content/figures/1744-8603-7-12-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2011-05-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/5/1/7">
        <title>Cardiovascular disease, diabetes and established risk factors among populations of sub-Saharan African descent in Europe: a literature review</title>
        <description>Background:
Most European countries are ethnically and culturally diverse. Globally, cardiovascular disease (CVD) is the leading cause of death. The major risk factors for CVD have been well established. This picture holds true for all regions of the world and in different ethnic groups. However, the prevalence of CVD and related risk factors vary among ethnic groups.
Methods:
This article provides a review of current understanding of the epidemiology of vascular disease, principally coronary heart disease (CHD), stroke and related risk factors among populations of Sub-Sahara African descent (henceforth, African descent) in comparison with the European populations in Europe.
Results:
Compared with European populations, populations of African descent have an increased risk of stroke, whereas CHD is less common. They also have higher rates of hypertension and diabetes than European populations. Obesity is highly prevalent, but smoking rate is lower among African descent women. Older people of African descent have more favourable lipid profile and dietary habits than their European counterparts. Alcohol consumption is less common among populations of African descent. The rate of physical activity differs between European countries. Dutch African-Suriname men and women are less physically active than the White-Dutch whereas British African women are more physically active than women in the general population. Literature on psychosocial stress shows inconsistent results.
Conclusion:
Hypertension and diabetes are highly prevalent among African populations, which may explain their high rate of stroke in Europe. The relatively low rate of CHD may be explained by the low rates of other risk factors including a more favourable lipid profile and the low prevalence of smoking. The risk factors are changing, and on the whole, getting worse especially among African women. Cohort studies and clinical trials are therefore needed among these groups to determine the relative contribution of vascular risk factors, and to help guide the prevention efforts. There is a clear need for intervention studies among these populations in Europe.</description>
        <link>http://www.globalizationandhealth.com/content/5/1/7</link>
                <dc:creator>Charles Agyemang</dc:creator>
                <dc:creator>Juliet Addo</dc:creator>
                <dc:creator>Raj Bhopal</dc:creator>
                <dc:creator>Ama de-Graft Aikins</dc:creator>
                <dc:creator>Karien Stronks</dc:creator>
                <dc:source>Globalization and Health 2009, null:7</dc:source>
        <dc:date>2009-08-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-5-7</dc:identifier>
                                <prism:require>/content/figures/1744-8603-5-7-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2009-08-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

